These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 622459)

  • 1. Migration inhibition of immune mouse spleen cells by from X-irradiated tumor-bearing mice.
    Moroson H
    Radiat Res; 1978 Jan; 73(1):192-200. PubMed ID: 622459
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
    Konda S; Smith RT
    Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
    [No Abstract]   [Full Text] [Related]  

  • 3. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunogenic activity of tumor antigens retained by the reticuloendothelial cells of tumor-bearing mice.
    Vaage J
    Cancer Res; 1972 May; 32(5):898-903. PubMed ID: 5017740
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
    Vaage J; Jones RD; Brown BW
    Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
    [No Abstract]   [Full Text] [Related]  

  • 7. Embryonic antigens shared between chemically induced lymphosarcomas and fibrosarcomas of the mouse.
    Ménard S; Colnaghi MI
    J Natl Cancer Inst; 1975 Feb; 54(2):479-81. PubMed ID: 1172784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tumor size on concomitant tumor immunity.
    Deckers PJ; Davis RC; Parker GA; Mannick JA
    Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of in vivo adsorption of immune serum to donor spleen cells on allograft rejection in X-irradiated mice.
    Cruse JM; Dulaney AD
    Z Immunitatsforsch Allerg Klin Immunol; 1966 May; 130(4):329-36. PubMed ID: 4231165
    [No Abstract]   [Full Text] [Related]  

  • 10. Murine splenic changes in response to syngeneic and allogeneic neoplasias.
    Braylan RC; Rumi L; Dosne Pasqualini C
    Medicina (B Aires); 1972; 32(5):505-10. PubMed ID: 4649563
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.
    Vaage J
    Cancer Res; 1974 Nov; 34(11):2979-83. PubMed ID: 4425091
    [No Abstract]   [Full Text] [Related]  

  • 12. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current topics on tumor immunology].
    Tachibana T
    Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor immunity induced by local radiotherapy].
    Yamashita T; Hayakawa Y; Hanajima K; Mochizuki S
    Gan No Rinsho; 1983 Oct; 29(13):1506-11. PubMed ID: 6422094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay.
    Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
    J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 20. Mediation of immunity to tumor-specific transplantation antigens by RNA inhibition of isograft growth in rats.
    Deckers PJ; Pilch YH
    Cancer Res; 1972 Apr; 32(4):839-46. PubMed ID: 5014793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.